288 related articles for article (PubMed ID: 15123681)
1. Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.
Hartman ME; O'Connor JC; Godbout JP; Minor KD; Mazzocco VR; Freund GG
J Biol Chem; 2004 Jul; 279(27):28045-50. PubMed ID: 15123681
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3.
O'Connor JC; Sherry CL; Guest CB; Freund GG
J Immunol; 2007 Jun; 178(11):6886-93. PubMed ID: 17513737
[TBL] [Abstract][Full Text] [Related]
3. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
Tzatsos A; Kandror KV
Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance.
Kim JA; Yeh DC; Ver M; Li Y; Carranza A; Conrads TP; Veenstra TD; Harrington MA; Quon MJ
J Biol Chem; 2005 Jun; 280(24):23173-83. PubMed ID: 15849359
[TBL] [Abstract][Full Text] [Related]
6. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
7. Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling.
Giraud J; Leshan R; Lee YH; White MF
J Biol Chem; 2004 Jan; 279(5):3447-54. PubMed ID: 14623899
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase.
Yamauchi T; Kaburagi Y; Ueki K; Tsuji Y; Stark GR; Kerr IM; Tsushima T; Akanuma Y; Komuro I; Tobe K; Yazaki Y; Kadowaki T
J Biol Chem; 1998 Jun; 273(25):15719-26. PubMed ID: 9624169
[TBL] [Abstract][Full Text] [Related]
9. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
[TBL] [Abstract][Full Text] [Related]
10. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation.
Greene MW; Sakaue H; Wang L; Alessi DR; Roth RA
J Biol Chem; 2003 Mar; 278(10):8199-211. PubMed ID: 12510059
[TBL] [Abstract][Full Text] [Related]
11. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
12. Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.
Li J; Houseknecht KL; Stenbit AE; Katz EB; Charron MJ
FASEB J; 2000 Jun; 14(9):1117-25. PubMed ID: 10834933
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells.
Briaud I; Dickson LM; Lingohr MK; McCuaig JF; Lawrence JC; Rhodes CJ
J Biol Chem; 2005 Jan; 280(3):2282-93. PubMed ID: 15537654
[TBL] [Abstract][Full Text] [Related]
14. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
[TBL] [Abstract][Full Text] [Related]
16. Shp2 is required for protein kinase C-dependent phosphorylation of serine 307 in insulin receptor substrate-1.
Müssig K; Staiger H; Fiedler H; Moeschel K; Beck A; Kellerer M; Häring HU
J Biol Chem; 2005 Sep; 280(38):32693-9. PubMed ID: 16055440
[TBL] [Abstract][Full Text] [Related]
17. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
18. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
19. Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake.
O'Connor JC; Freund GG
Metabolism; 2003 Jun; 52(6):666-74. PubMed ID: 12800089
[TBL] [Abstract][Full Text] [Related]
20. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.
Aytug S; Reich D; Sapiro LE; Bernstein D; Begum N
Hepatology; 2003 Dec; 38(6):1384-92. PubMed ID: 14647049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
